Scholars Central

Conference abstractPublished 2019

Development and preclinical evaluation of novel microparticulate vaccine formulation for the treatment of metastatic breast cancer

Authors: Rokon Uz Zaman

Mercer University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Purpose: The aim of the study was to formulate a microparticulate vaccine formulation for metastatic breast cancer by using a murine metastatic breast cancer cell line 4T1 for transdermal administration through microneedles. Introduction: Breast cancer (BC) is the most commonly diagnosed malignancy and is the second leading cause of cancer related death in American women. For this reason development of a therapeutic breast cancer vaccine is an area of research that needs urgent attention offering these women a better chance of a cancer free life. Many therapeutic vaccine strategies are under clinical trials for breast cancer but currently there are no FDA approved vaccines for breast cancer. Therefore an optimum cancer vaccine with characteristics like, rapid production time, ease of delivery, and the ability to be customizable for individual patients is an area of interest in cancer research. Our microparticle-based vaccine approach, addresses many of the problems associated with the current vaccine therapies including the high vaccine costs. We have developed a novel formulation using sustained release polymers encapsulating antigens in a biodegradable matrix containing immune potentiator adjuvants.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Vaccines & Clinical Trials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Clinical Trials
  • SubjectPharmaceutical Sciences
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Rokon Uz Zaman”